{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:23:00Z","timestamp":1792480980159,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["\/NIAID UM1 AI179699"],"award-info":[{"award-number":["\/NIAID UM1 AI179699"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["INV-027276"],"award-info":[{"award-number":["INV-027276"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-002483"],"award-info":[{"award-number":["INV-002483"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.isci.2025.111932","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:30:44Z","timestamp":1738207844000},"page":"111932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Predicting tuberculosis drug efficacy in preclinical and clinical models from in\u00a0vitro data"],"prefix":"10.1016","volume":"28","author":[{"given":"Janice J.N.","family":"Goh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Ngara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob C.","family":"van Wijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Strydom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhi","family":"Van","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy M.","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Nuermberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bree B.","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Roubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jansy","family":"Sarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Dartois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rada M.","family":"Savic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.111932_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciw566","article-title":"Executive Summary: Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2025.111932_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002884","article-title":"The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials","volume":"16","author":"Vernon","year":"2019","journal-title":"PLoS Med."},{"key":"10.1016\/j.isci.2025.111932_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","article-title":"Anti-tuberculosis treatment strategies and drug development: challenges and priorities","volume":"20","author":"Dartois","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2025.111932_bib5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.isci.2025.111932_bib6","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1371\/journal.pmed.0040120","article-title":"Why is long-term therapy required to cure tuberculosis?","volume":"4","author":"Connolly","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.isci.2025.111932_bib7","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.2147\/IDR.S419996","article-title":"The Safety and Efficacy of Prolonged Use of Bedaquiline for the Treatment of Patients with Pulmonary Multi-Drug Resistant\/Rifampin-Resistant Tuberculosis: A Prospective, Cohort Study in China","volume":"16","author":"Ke","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.isci.2025.111932_bib8","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1128\/AAC.06288-11","article-title":"Targeting persisters for tuberculosis control","volume":"56","author":"Zhang","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00165-2023","article-title":"Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs","volume":"62","author":"Ernest","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.isci.2025.111932_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1128\/AAC.03823-14","article-title":"In\u00a0vitro and in\u00a0vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis","volume":"59","author":"Upton","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222970","article-title":"A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis","volume":"14","author":"Early","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.111932_bib12","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1128\/AAC.00803-15","article-title":"Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis","volume":"59","author":"Gold","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib13","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/acsinfecdis.9b00112","article-title":"Dual-pharmacophore pyrithione-containing cephalosporins kill both replicating and nonreplicating Mycobacterium tuberculosis","volume":"5","author":"Lopez Quezada","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.isci.2025.111932_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02266-17","article-title":"Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum","volume":"62","author":"Sarathy","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2023.102318","article-title":"Adaptation to the intracellular environment of primary human macrophages influences drug susceptibility of Mycobacterium tuberculosis","volume":"139","author":"Lanni","year":"2023","journal-title":"Tuberculosis"},{"key":"10.1016\/j.isci.2025.111932_bib16","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.cels.2021.08.004","article-title":"Systematic measurement of combination-drug landscapes to predict in\u00a0vivo treatment outcomes for tuberculosis","volume":"12","author":"Larkins-Ford","year":"2021","journal-title":"Cell Syst."},{"key":"10.1016\/j.isci.2025.111932_bib17","series-title":"Role of macrophages during HIV-1 infection and in the context of co-infection with Mycobacterium tuberculosis","author":"Souriant","year":"2017"},{"key":"10.1016\/j.isci.2025.111932_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.668060","article-title":"Integrative Analysis of Human Macrophage Inflammatory Response Related to Mycobacterium tuberculosis Virulence","volume":"12","author":"Bade","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.111932_bib19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jac\/dku457","article-title":"Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents","volume":"70","author":"Lakshminarayana","year":"2015","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib20","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1128\/AAC.02202-12","article-title":"Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis","volume":"57","author":"Sarathy","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib21","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1128\/AAC.00055-06","article-title":"Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis","volume":"51","author":"Cho","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib22","doi-asserted-by":"crossref","first-page":"25273","DOI":"10.1074\/jbc.M803899200","article-title":"Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis","volume":"283","author":"Koul","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2025.111932_bib23","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1128\/AAC.49.11.4778-4780.2005","article-title":"Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates","volume":"49","author":"Xie","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00856-18","article-title":"Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In\u00a0Vitro Assay","volume":"62","author":"de Miranda Silva","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00693-21","article-title":"Building Optimal Three-Drug Combination Chemotherapy Regimens To Eradicate Mycobacterium tuberculosis in Its Slow-Growth Acid Phase","volume":"65","author":"Kim","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00221-18","article-title":"Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model","volume":"62","author":"Drusano","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2023.01.043","article-title":"Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents","volume":"186","author":"Zhang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111932_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00132-22","article-title":"GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In\u00a0Vivo with the Potential To Shorten Tuberculosis Treatment","volume":"66","author":"Nuermberger","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00282-21","article-title":"In\u00a0Vitro Profiling of Antitubercular Compounds by Rapid, Efficient, and Nondestructive Assays Using Autoluminescent Mycobacterium tuberculosis","volume":"65","author":"Shetye","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/imr.12252","article-title":"Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses","volume":"264","author":"Lenaerts","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.isci.2025.111932_bib31","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nri.2017.69","article-title":"Heterogeneity in tuberculosis","volume":"17","author":"Cadena","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2025.111932_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41579-022-00721-0","article-title":"Types and functions of heterogeneity in mycobacteria","volume":"20","author":"Chung","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2025.111932_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01727-19","article-title":"Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies","volume":"64","author":"Zhang","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.111932_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.tube.2003.12.003","article-title":"Resistance and susceptibility to tuberculosis analysed at the transcriptome level: lessons from mouse macrophages","volume":"84","author":"Keller","year":"2004","journal-title":"Tuberculosis"},{"key":"10.1016\/j.isci.2025.111932_bib35","doi-asserted-by":"crossref","first-page":"8560","DOI":"10.1073\/pnas.150227197","article-title":"Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis","volume":"97","author":"Kramnik","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.111932_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00159-19","article-title":"Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters","volume":"33","author":"Sarathy","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2025.111932_bib37","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/JB.00305-09","article-title":"Acid resistance in Mycobacterium tuberculosis","volume":"191","author":"Vandal","year":"2009","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.isci.2025.111932_bib38","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3389\/fmicb.2018.01028","article-title":"Macrophage Heterogeneity in the Immunopathogenesis of Tuberculosis","volume":"9","author":"Marakalala","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2025.111932_bib39","series-title":"Encyclopedia of Machine Learning","first-page":"600","article-title":"Leave-One-Out Cross-Validation","year":"2010"},{"key":"10.1016\/j.isci.2025.111932_bib40","article-title":"Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs","author":"Ernest","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2025.111932_bib41","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","article-title":"Review: a gentle introduction to imputation of missing values","volume":"59","author":"Donders","year":"2006","journal-title":"J.\u00a0Clin. Epidemiol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225001920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225001920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T01:06:52Z","timestamp":1786410412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225001920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2589004225001920"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.111932","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting tuberculosis drug efficacy in preclinical and clinical models from in\u00a0vitro data","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.111932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111932"}}